Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMProBaCist-Q: Uroxin 4G for Recurrent Cystitis
NCT06659016Phase 4Completed
- Sponsor
- University of Campania Luigi Vanvitelli
- Start
- Feb 2023
- Primary completion
- Feb 2024
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (3 arms), sponsored by University of Campania Luigi Vanvitelli. Primary endpoint: Number of urinary tract infections per month at 12 months. Started Feb 2023; status: completed.
Beyond the preview
Go deeper on NCT06659016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06659016.